Jazz Pharmaceuticals JAZZ Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's income tax?
- Jazz Pharmaceuticals (JAZZ) reported income tax of $6.1M in Q1 2026.
- How has Jazz Pharmaceuticals's income tax changed year-over-year?
- Jazz Pharmaceuticals's income tax increased by 134.3% year-over-year, from -$17.8M to $6.1M.
- What is the long-term trend for Jazz Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's income tax has grown at a 5.0% compound annual growth rate (CAGR), from $228.58M to -$277.39M.
- What does income tax mean?
- The total tax cost recognized by the company for the period.
- How do you interpret income tax?
- Fluctuations often reflect changes in statutory tax rates, tax credits, or the utilization of deferred tax assets.
- How does income tax compare across companies?
- Standard tax provision metric for all corporations.